SC: Insurer Must Pay Accident Compensation Despite Route Permit Violation, Recoverable From Owner  ||  SC: Recovery of Currency Alone Doesn’t Convict under PC Act Without Proof of Demand and Acceptance  ||  SC: Minor Variations in Later Statements Don’t Undermine First Dying Declaration if Reliable  ||  SC: Members of Unlawful Assembly Liable under Section 149 IPC Once Common Object is Proven  ||  Madras HC: Grandparents Can Execute Adoption Deed for Unmarried Daughter if She Consents  ||  Delhi HC: Guilty Plea Doesn’t Bypass Double Jeopardy; Second Conviction for Same Offence Invalid  ||  Del HC: Provision of Recall u/s 311 CrPC Ensures Justice, Not Multiple Chances to Negligent Litigant  ||  AP HC: Shutdown of Specific Unit Constitutes Closure, Workers Entitled to Compensation under S.25FFF  ||  P&H High Court: Over-Implication of Accused’s Relatives Turns Criminal Process Into Harassment  ||  Delhi HC: Denying Candidature of Physically Disabled Person Due to 'No Vacancy' Violates RPwD Act    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved